Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice

NeuroReport

Volumn 15, Issue 14, 2004, Pages 2245-2249

  Francès, Henriette ^a,b   Le Foll, Bernard ^a   Diaz, Jorge ^a,c   Smirnova, Maria ^b   Sokoloff, Pierre ^a  

^a INSERM   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BP 897; c fos; Conditioned place preference; Dopamine D3 receptor; Mouse

Indexed keywords

BP 897; COCAINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR PARTIAL AGONIST; GENE PRODUCT; MORPHINE; OPIATE; PROTEIN DRD3; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRD3 GENE; GENE; GENE EXPRESSION REGULATION; IMAGE ANALYSIS; KNOCKOUT MOUSE; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; ONCOGENE C FOS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATOSENSORY CORTEX; WILD TYPE;

ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 6344269536     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200410050-00021     Document Type: Article

References (24)

1. Goldberg SR and Gardner ML. Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration. NIDA Res Monogr 1981; 37:241-270.
2. O'Brien CP, Childress AR, McMellan AT and Ehrman RA. A learning model of addiction. Res Publ Assoc Res Nerv Ment Dis 1992; 70:157-177.
3. Mirenowicz J and Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996; 379:449-451.
4. 3 receptor agonist. Nature 1999; 400:371-375.
5. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002; 22:9595-9603.
6. 3 receptor antagonist SB-277011-A. Neuropsychopharmacology 2003; 28:329-338.
7. 3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 2002; 15:2016-2026.
8. 3 receptor ligands. Mol Psychiatry 2003; 8:225-230.
9. Duarte C, Lefebvre C, Chaperon F, Hamon M and Thiebot MH. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 2003; 28:1903-1915.
10. Di Chiara G and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85:5274-5278.
11. vanRee JM, Gerrits MA and Vanderschuren LJ. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 1999; 51:341-396.
12. 3 receptor antagonist SB-277011 A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 2003; 48:154-156.
13. 3 receptors. Soc Neurosci Abstr 2001; 27:616.
14. 3 receptor ligands modulate the acquisition of morphine-conditioned place preference. Psychopharmacology (Berl) 2004, in press.
15. Bezard E, Ferry S, Mach U, Leriche L, Boraud T, Stark H et al. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nature Med 2003; 6:762-767.
16. 3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 2000; 15:140-146.
17. 3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci 2003; 23:1006-1012.
18. Bardo MT, Rowlett JK and Harris MJ. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 1995; 19:39-51.
19. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 2000; 20:8677-8684.
20. Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998; 18:2231-2238.
21. 3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology 2001; 41:351-359.
22. Carr GD, Fibiger HC and Phillips AG. In: Liebman JM and Cooper SJ (eds). The Neuropharmacological Basis of Reward. Oxford: Clarendon Press; 1989, pp. 264-319.
23. Phillips AG, LePiane FG and Fibiger HC. Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of the rat. Life Sci 1983; 33:2505-2511.
24. Kelsey JE and Arnold SR. Lesions of the dorsomedial amygdala, but not the nucleus accumbens reduce the aversiveness of morphine withdrawal in rats. Behav Neurosci 1994; 108:1119-1127.